We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$97B
AUM Growth
-$517M
Cap. Flow
-$315M
Cap. Flow %
-0.32%
Top 10 Hldgs %
37.18%
Holding
506
New
13
Increased
130
Reduced
158
Closed
20

Top Buys

Rank Stock Value
1
ESTC icon
Elastic
ESTC
+$386M
2
MELI icon
Mercado Libre
MELI
+$307M
3
NU icon
Nu Holdings
NU
+$265M
4
SHOP icon
Shopify
SHOP
+$254M
5
RBLX icon
Roblox
RBLX
+$253M

Top Sells

Rank Stock Value
1
BYND icon
Beyond Meat
BYND
+$232M
2
LI icon
Li Auto
LI
+$219M
3
ILMN icon
Illumina
ILMN
+$187M
4
ALB icon
Albemarle
ALB
+$178M
5
RACE icon
Ferrari
RACE
+$147M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.03%
2 Healthcare 24.31%
3 Technology 16.9%
4 Communication Services 11.22%
5 Financials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ON icon
301
ON Semiconductor
ON
$31.6B
$34K ﹤0.01%
548
-27
-5% -$1.74K
UNH icon
302
UnitedHealth
UNH
$370B
$34K ﹤0.01%
67
BMY icon
303
Bristol-Myers Squibb
BMY
$132B
$33K ﹤0.01%
458
-30
-6% -$2.18K
REGN icon
304
Regeneron Pharmaceuticals
REGN
$80.8B
$32K ﹤0.01%
47
-3
-6% -$1.89K
DOX icon
305
Amdocs
DOX
$6.22B
$31K ﹤0.01%
386
AMKR icon
306
Amkor Technology
AMKR
$13.7B
$30K ﹤0.01%
1,786
-190
-10% -$3.66K
COST icon
307
Costco
COST
$420B
$30K ﹤0.01%
63
HALO icon
308
Halozyme
HALO
$12.2B
$30K ﹤0.01%
763
-52
-6% -$2.3K
GWW icon
309
W.W. Grainger
GWW
$60.2B
$29K ﹤0.01%
60
INSP icon
310
Inspire Medical Systems
INSP
$1.74B
$29K ﹤0.01%
162
-11
-6% -$2.21K
TSCO icon
311
Tractor Supply
TSCO
$18B
$29K ﹤0.01%
775
SPWR
312
DELISTED
SunPower Corporation Common Stock
SPWR
$28K ﹤0.01%
1,210
HUM icon
313
Humana
HUM
$46.2B
$27K ﹤0.01%
55
-5
-8% -$2.43K
FDS icon
314
Factset
FDS
$10.2B
$24K ﹤0.01%
61
BOX icon
315
Box
BOX
$4.6B
$23K ﹤0.01%
924
-55
-6% -$1.51K
CELH icon
316
Celsius Holdings
CELH
$7.03B
$23K ﹤0.01%
762
+72
+10% +$2.25K
VC icon
317
Visteon
VC
$2.78B
$23K ﹤0.01%
218
-12
-5% -$1.43K
APPF icon
318
AppFolio
APPF
$7.04B
$22K ﹤0.01%
212
AZN icon
319
AstraZeneca
AZN
$250B
$22K ﹤0.01%
200
GGG icon
320
Graco
GGG
$13.5B
$22K ﹤0.01%
363
JAZZ icon
321
Jazz Pharmaceuticals
JAZZ
$16.7B
$22K ﹤0.01%
168
POOL icon
322
Pool Corp
POOL
$7.5B
$22K ﹤0.01%
70
SRPT icon
323
Sarepta Therapeutics
SRPT
$1.77B
$22K ﹤0.01%
199
BCRX icon
324
BioCryst Pharmaceuticals
BCRX
$2.4B
$21K ﹤0.01%
1,687
BPMC
325
DELISTED
Blueprint Medicines
BPMC
$21K ﹤0.01%
315

Similar funds

Baillie Gifford & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Baillie Gifford & Co held 506 positions worth $97B, down 0.53% from $97.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Baillie Gifford & Co's Q3 2022 filing shows 13 new, 130 increased, 158 reduced and 20 closed positions. Its largest new stake was Elastic: 4,847,733 shares worth $348M. The largest sale was Beyond Meat, an estimated $232M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q3 2022 buy was Elastic: 4,847,733 shares worth $348M.
  • Baillie Gifford & Co added most to Mercado Libre in Q3 2022, an estimated $307M increase.
  • Baillie Gifford & Co's biggest Q3 2022 reduction was Beyond Meat, cutting an estimated $232M.
  • Baillie Gifford & Co fully exited Zai Lab in Q3 2022, selling an estimated $25.5M.
  • Baillie Gifford & Co's ten largest holdings make up 37% of its $97B portfolio in Q3 2022.
  • Baillie Gifford & Co opened 13 new positions and closed 20 in Q3 2022.
  • Baillie Gifford & Co's portfolio value fell 0.53% quarter-over-quarter to $97B.

Based on Baillie Gifford & Co's 13F filing for Q3 2022, filed 27 Oct 2022.